Overview

Efficacy and Safety of ZSP1273 in Children 2-11 Years Old With Influenza A

Status:
NOT_YET_RECRUITING
Trial end date:
2026-09-17
Target enrollment:
Participant gender:
Summary
This trial is conducted in China. The aim of the trial is to investigate safety and efficacy of ZSP1273 granules
Phase:
PHASE3
Details
Lead Sponsor:
Guangdong Raynovent Biotech Co., Ltd
Treatments:
Oseltamivir
ZSP1273